You are here: Industry Insights > cancer

News List

Millions of Life Years, Billions of Dollars Lost to Cancer Each Year drugs
July 04, 2019
More than 8.7 million years of life and about $94 billion in earnings were lost to cancer in the United States in 2015, researchers say.
Zirabev gets FDA approval to treat five types of cancer pharmaceutical-technology
July 03, 2019
Pfizer has secured US Food and Drug Administration (FDA) approval for Zirabev (bevacizumab-bvzr), a biosimilar to Roche’s Avastin (bevacizumab).
MS Linked to Higher Cancer Risk drugs
July 02, 2019
Multiple sclerosis is a tough disease to manage and live with, but a new, long-running Norwegian study suggests it might also raise cancer risk.
Cancer Risk Rises After Iodine Rx for Overactive Thyroid: Study drugs
July 02, 2019
Patients who receive radioactive iodine treatment for an overactive thyroid have an increased long-term risk of cancer death, new research finds.
MammaPrint? Becomes Only Molecular Diagnostic Recommended for Early-Stage Node-Positive Breast Cancer Patients in ASCO-Endorsed Cancer Care Ontario Guidelines b3cnewswire
July 01, 2019
MammaPrint? Becomes Only Molecular Diagnostic Recommended for Early-Stage Node-Positive Breast Cancer Patients in ASCO-Endorsed Cancer Care Ontario Guidelines.
IMFINZI? Improves OS at Interim Analysis in CASPIAN Trial in Small Cell Lung Cancer americanpharmaceuticalreview
June 28, 2019
AstraZeneca announced positive overall survival (OS) results from the Phase III CASPIAN trial with IMFINZI in 1st-line extensive-stage small cell lung cancer (SCLC), a disease with significant unmet need and limited treatment options for patients.
Early Risers May Be a Little Less Likely to Get Breast Cancer drugs
June 28, 2019
Early Risers May Be a Little Less Likely to Get Breast Cancer.
USPSTF Lung Cancer Screening Too Conservative for Blacks drugs
June 28, 2019
USPSTF Lung Cancer Screening Too Conservative for Blacks.
Inovio Completes Enrollment of VGX-3100 Phase 3 Trial (REVEAL 1) for the Treatment of HPV-Related Cervical Pre-cancer En-CPhI.cn
June 27, 2019
Inovio Pharmaceuticals announced the completion of target enrollment of 198 participants for its pivotal Phase 3 registration trial of VGX-3100
Combination Biopsy Strategy May Identify More Prostate Cancers drugs
June 27, 2019
Combination Biopsy Strategy May Identify More Prostate Cancers.